Logo image of MSPR

MSP RECOVERY INC (MSPR) Stock Fundamental Analysis

USA - NASDAQ:MSPR - US5537453087 - Common Stock

1.18 USD
-0.13 (-9.92%)
Last: 9/30/2025, 11:39:25 AM
Fundamental Rating

2

Taking everything into account, MSPR scores 2 out of 10 in our fundamental rating. MSPR was compared to 101 industry peers in the Health Care Providers & Services industry. MSPR has a bad profitability rating. Also its financial health evaluation is rather negative. MSPR has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MSPR has reported negative net income.
In the past year MSPR has reported a negative cash flow from operations.
MSPR had negative earnings in each of the past 5 years.
MSPR had negative operating cash flow in 4 of the past 5 years.
MSPR Yearly Net Income VS EBIT VS OCF VS FCFMSPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M -400M -500M

1.2 Ratios

Looking at the Return On Assets, with a value of -34.72%, MSPR is doing worse than 88.12% of the companies in the same industry.
Industry RankSector Rank
ROA -34.72%
ROE N/A
ROIC N/A
ROA(3y)-6.93%
ROA(5y)-37.77%
ROE(3y)-128.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MSPR Yearly ROA, ROE, ROICMSPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

The Gross Margin of MSPR (34.88%) is better than 66.34% of its industry peers.
In the last couple of years the Gross Margin of MSPR has declined.
The Profit Margin and Operating Margin are not available for MSPR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.71%
GM growth 5YN/A
MSPR Yearly Profit, Operating, Gross MarginsMSPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

1

2. Health

2.1 Basic Checks

MSPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MSPR has less shares outstanding
MSPR has less shares outstanding than it did 5 years ago.
MSPR has a worse debt/assets ratio than last year.
MSPR Yearly Shares OutstandingMSPR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1B 2B 3B
MSPR Yearly Total Debt VS Total AssetsMSPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

MSPR has an Altman-Z score of -1.99. This is a bad value and indicates that MSPR is not financially healthy and even has some risk of bankruptcy.
MSPR has a worse Altman-Z score (-1.99) than 85.15% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.99
ROIC/WACCN/A
WACC0.3%
MSPR Yearly LT Debt VS Equity VS FCFMSPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

MSPR has a Current Ratio of 0.01. This is a bad value and indicates that MSPR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of MSPR (0.01) is worse than 96.04% of its industry peers.
MSPR has a Quick Ratio of 0.01. This is a bad value and indicates that MSPR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.01, MSPR is not doing good in the industry: 96.04% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
MSPR Yearly Current Assets VS Current LiabilitesMSPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

6

3. Growth

3.1 Past

The earnings per share for MSPR have decreased strongly by -256.26% in the last year.
Looking at the last year, MSPR shows a very strong growth in Revenue. The Revenue has grown by 76.98%.
The Revenue has been growing slightly by 7.65% on average over the past years.
EPS 1Y (TTM)-256.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.5%
Revenue 1Y (TTM)76.98%
Revenue growth 3Y7.65%
Revenue growth 5YN/A
Sales Q2Q%59.05%

3.2 Future

The Earnings Per Share is expected to grow by 147.54% on average over the next years. This is a very strong growth
Based on estimates for the next years, MSPR will show a very strong growth in Revenue. The Revenue will grow by 145.11% on average per year.
EPS Next Y145.1%
EPS Next 2Y147.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year197.69%
Revenue Next 2Y145.11%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MSPR Yearly Revenue VS EstimatesMSPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 10B 20B 30B 40B
MSPR Yearly EPS VS EstimatesMSPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2K 4K 6K 8K

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MSPR. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 0.01, the valuation of MSPR can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MSPR indicates a rather cheap valuation: MSPR is cheaper than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.13, MSPR is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 0.01
MSPR Price Earnings VS Forward Price EarningsMSPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MSPR Per share dataMSPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -500 -1K

4.3 Compensation for Growth

MSPR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MSPR's earnings are expected to grow with 147.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y147.54%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MSPR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MSP RECOVERY INC

NASDAQ:MSPR (9/30/2025, 11:39:25 AM)

1.18

-0.13 (-9.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-07 2025-08-07
Earnings (Next)11-12 2025-11-12
Inst Owners7.9%
Inst Owner Change0%
Ins Owners19.76%
Ins Owner Change0%
Market Cap1.66M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short Ratio0.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.01
P/S 0.13
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-255.66
EYN/A
EPS(NY)191.19
Fwd EY16202.33%
FCF(TTM)-16.42
FCFYN/A
OCF(TTM)-14.62
OCFYN/A
SpS9.42
BVpS-146.92
TBVpS-1324.89
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -34.72%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.88%
FCFM N/A
ROA(3y)-6.93%
ROA(5y)-37.77%
ROE(3y)-128.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.71%
GM growth 5YN/A
F-Score2
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.53%
Cap/Sales 19.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z -1.99
F-Score2
WACC0.3%
ROIC/WACCN/A
Cap/Depr(3y)1.07%
Cap/Depr(5y)43.68%
Cap/Sales(3y)23.63%
Cap/Sales(5y)15.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-256.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.5%
EPS Next Y145.1%
EPS Next 2Y147.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)76.98%
Revenue growth 3Y7.65%
Revenue growth 5YN/A
Sales Q2Q%59.05%
Revenue Next Year197.69%
Revenue Next 2Y145.11%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y53.51%
OCF growth 3YN/A
OCF growth 5YN/A